3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase 3
3
Phase 1
3
Phase 4
2
Phase 1/2
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Thyroid Neoplasms
2
Kidney Neoplasms
2
Carcinoma, Renal Cell
2
Neoplasm Metastasis
1
Carcinoma, Medullary
1
Interventions
Nivolumab
4
cabozantinib
2
Sodium Chloride
2
Saline Solution
2
Everolimus
2
Anesthesia, Epidural
2
polyethylene glycol 3350
1
aldesleukin
1
Tobacco Use Cessation Devices
1
Standard of Care
1
Solutions
1
Sevoflurane
1
Radiotherapy
1
Psychiatric Rehabilitation
1
Propofol
1
Polymerase Chain Reaction
1
Papaverine
1
Nutrition Therapy
1
Neuroleptanalgesia
1
Lidocaine
1
Ipilimumab
1
Intubation
1
Hydroxyethyl Starch Derivatives
1
HES 130-0.4
1
Glucose
1
Gene Expression Profiling
1
Fentanyl
1
Early Intervention, Educational
1
Dexmedetomidine
1
Counseling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Kidney Neoplasms
×
cabozantinib
×
Clear all
NCT07028125
2026-06-05
CANIQOL
Centre Francois Baclesse
Phase 4
Recruiting
83 enrolled
NCT06934057
2025-09-24
CABOLD
Gustave Roussy, Cancer Campus, Grand Paris
Phase 4
Recruiting
50 enrolled